Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitigation of abiotic stresses refers to the broad physiological and molecular mechanisms by which organisms, primarily plants, adapt to and survive adverse non-living environmental conditions such as drought, salinity, extreme temperatures, and heavy metal toxicity. Rather than representing a single molecular target like a specific receptor or enzyme, it encompasses a complex network of pathways including the ABA-dependent and independent signaling routes, the production of osmoprotectants, and the upregulation of heat shock proteins and antioxidant systems (NCBI, PMC7070381). In agricultural biotechnology, this process is a major focus for crop improvement, where researchers target specific components like DREB transcription factors or MAP kinase cascades to enhance resilience (PubMed, 32333469). Because the term describes a phenotypic outcome or a collective biological process rather than a discrete protein or nucleic acid, it is not classified as a standard therapeutic target in human pharmacology.
Activation of multifaceted signaling networks involving phytohormones, transcription factors, and antioxidant enzymes to restore cellular homeostasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitigation of abiotic stresses.